Cargando…

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic (DAergic) neurons and the presence of α-synuclein-containing Lewy bodies. The unstructured α-synuclein forms insoluble fibrils and aggregates that result in increased reactive oxygen species (RO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chiung-Mei, Yen, Chien-Yu, Chen, Wan-Ling, Lin, Chih-Hsin, Wu, Yih-Ru, Chang, Kuo-Hsuan, Lee-Chen, Guey-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865530/ https://www.ncbi.nlm.nih.gov/pubmed/33494411 http://dx.doi.org/10.3390/ijms22031062

Ejemplares similares

Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation
por: Chiu, Ya-Jen, et al.
Publicado: (2020)

Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy
por: Lin, Chih-Hsin, et al.
Publicado: (2020)

Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2023)

Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022)

STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015)

Rare VPS35 A320V Variant in Taiwanese Parkinson’s Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology
por: Wu, Yih-Ru, et al.
Publicado: (2020)

Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
por: Grotemeyer, Alexander, et al.
Publicado: (2022)

Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Genetic Analysis of EGLN1 C127S Variant in Taiwanese Parkinson's Disease
por: Chiang, Han-Lin, et al.
Publicado: (2020)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
por: Wei, Pei-Cih, et al.
Publicado: (2019)

Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability
por: Chen, Chiung Mei, et al.
Publicado: (2020)

Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement
por: Chiu, Ya-Jen, et al.
Publicado: (2021)

New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models
por: Chen, Chiung-Mei, et al.
Publicado: (2020)

Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity
por: Yang, Pei-Ning, et al.
Publicado: (2023)

Aqueous Extract of Paeonia lactiflora and Paeoniflorin as Aggregation Reducers Targeting Chaperones in Cell Models of Spinocerebellar Ataxia 3
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models
por: Chen, Chiung-Mei, et al.
Publicado: (2019)

Freshwater Clam Extract Mitigates Neuroinflammation and Amplifies Neurotrophic Activity of Glia: Insights from In Vitro Model of Neurodegenerative Pathomechanism
por: Lin, Muh-Shi, et al.
Publicado: (2022)

Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation
por: Chen, I-Cheng, et al.
Publicado: (2018)

The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer’s disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2016)

FBXO7 Y52C Polymorphism as a Potential Protective Factor in Parkinson's Disease
por: Chen, Chiung-Mei, et al.
Publicado: (2014)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Exploration of multi‐target effects of 3‐benzoyl‐5‐hydroxychromen‐2‐one in Alzheimer’s disease cell and mouse models
por: Lin, Te‐Hsien, et al.
Publicado: (2020)

Isorhamnetin Attenuated the Release of Interleukin-6 from β-Amyloid-Activated Microglia and Mitigated Interleukin-6-Mediated Neurotoxicity
por: Wei, Pei-Cih, et al.
Publicado: (2022)

The Role of Oxidative Stress in Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2020)

Altered Aconitase 2 Activity in Huntington’s Disease Peripheral Blood Cells and Mouse Model Striatum
por: Chen, Chiung-Mei, et al.
Publicado: (2017)

Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s disease patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2017)

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
por: Limphaibool, Nattakarn, et al.
Publicado: (2019)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Internal Ribosome Entry Segment Activity of ATXN8 Opposite Strand RNA
por: Chen, I-Cheng, et al.
Publicado: (2013)

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2012)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations
por: Wu, Yih Ru, et al.
Publicado: (2012)

Using ΔK280 Tau(RD) Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy
por: Weng, Zheng-Kui, et al.
Publicado: (2023)

The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases
por: Hsueh, Yi-Jen, et al.
Publicado: (2022)

Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan
por: Chen, Yi-Chun, et al.
Publicado: (2016)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
por: Ko, Chih-Jan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qnf9dqrri2ae8g3sjtbehu4neb